We investigated a cohort of 197 patients who underwent RPE between 1995–2009 and met the EAU criteria for AS including PSA <10 ng/ml, biopsy GS 6 with ≤2 cancer-positive cores and ≤50% of any core involved with tumor, clinical stage ≤T2a [4]. This evidence concerns the gene KLK3 and neoplasm.